arrow
Back
T

Toni K. Choueiri

dana-farber cancer institute

149H-index
2.4KPaper Count
12.6WCitation Count
Published Papers 660
Publication Date
Fusion-driven oncogenic programs shape the immune landscape in translocation renal cell carcinoma
err2026-08-26
err0
errOAAI
errPrathyusha Konda; Alexandra J. Wakolbinger; Yantong Cui; Gabriel Roberti de Oliveira; Yasmin L. Nabil; Cary N. Weiss; Maxwell D. Seager; Riva Deodhar; Jiao Li; Sayed Matar; Jinyu Wang; Jack Horst; Sabrina Y. Camp; Aseman B. Sheshdeh; Jonathan L. Hecht; David J. Einstein; Yashika Rustagi; Anwesha Nag; Aaron R. Thorner; Cheng-Zhong Zhang; Eliezer M. Van Allen; Sabina Signoretti; Toni K. Choueiri; Srinivas R. Viswanathan
errShare
errSave
Author Correction: Casdatifan shows durable response linked to HIF-2α biology in kidney cancer
errNature
IF48.5
err2026-08-04
err0
errOAAI
errToni K. Choueiri; Jaime Merchán; Amita Patnaik; Alexandra Drakaki; Brian I. Rini; Sun Young Rha; Jae Lyun Lee; Moshe C. Ornstein; Rohit Kumar; Clara Hwang; Yusra Shao; Se Hoon Park; Pedro C. Barata; Bradley A. McGregor; Paul Foster; Jianfen Chen; Melissa Eisen; Hunter Cole; Ben Weeder; Yinghui Guan; Jaskirat Singh; Angelo Kaplan; Soonweng Cho; Richard Markus; Omar Kabbarah; Rana R. McKay
errShare
errSave
Tertiary lymphoid structures harbour stem-like tumour-specific T cells
errNature
IF48.5
err2026-07-22
err0
PREAI
errAlexander B. Afeyan; Adi Nagler; Chloe R. Tu; Gabriel Roberti De Oliveira; Berkay Simsek; Maxwell D. Seager; Nourhan El Ahmar; Haley E. Sax; Emma Lin; Amit Sud; Mehdi Borji; Cleo Forman; Sophia Liu; Patrick A. Ott; Toni K. Choueiri; Jennifer G. Abelin; Richard Burack; Shuqiang Li; Kenneth J. Livak; Svitlana Tyekucheva; Derin B. Keskin; Fei Chen; Michael B. Atkins; Jeremy M. Simon; Sabina Signoretti; Giacomo Oliveira; David A. Braun; Catherine J. Wu
errShare
errSave
Single-nucleus multimodal spatial transcriptomics reveals spatial colocalization of neoantigen-expressing tumor cells and cognate T cells
err2026-07-22
err0
PREAI
errAdi Nagler; Amit Sud; Jack Y. Ghannam; Lucas Pomerance; Camila Robles-Oteiza; Alexander B. Afeyan; Jackson A. Weir; Andrew J. C. Russell; Wesley S. Lu; McKayla Van Orden; Andrea Sonnenholzner; Giovanni J. Marrero; Qiyu Gong; Vipin Kumar; Kun Huang; Chloe Tu; Emma Lin; Bohoon Shim; Gabriel R. De Oliveira; MacLean C. Sellars; Charles H. Yoon; David A. Reardon; Toni K. Choueiri; Lars R. Olsen; Sabina Signoretti; Patrick A. Ott; David A. Braun; Giacomo Oliveira; Shuqiang Li; Kenneth J. Livak; Nir Hacohen; Fei Chen; Catherine J. Wu
errShare
errSave
Casdatifan shows durable response linked to HIF-2α biology in kidney cancer
errNature
IF48.5
err2026-07-01
err0
errOAAI
errToni K. Choueiri; Jamie Merchan; Amita Patnaik; Alexandra Drakaki; Brian I. Rini; Sun Young Rha; Jae Lyun Lee; Moshe C. Ornstein; Rohit Kumar; Clara Hwang; Yusra Shao; Se Hoon Park; Pedro C. Barata; Bradley A. McGregor; Paul Foster; Jianfen Chen; Melissa Eisen; Hunter Cole; Ben Weeder; Yinghui Guan; Jaskirat Singh; Angelo Kaplan; Soonweng Cho; Richard Markus; Omar Kabbarah; Rana R. McKay
errShare
errSave
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling
err2026-06-25
err0
errOAAI
errDéborah Suissa; Marine Fidelle; Ella Reich; Thao-Nguyen Pham; Simon Thomas; Johannes R. Björk; Peng Liu; Liwei Zhao; Koji Kitaoka; Eléonore Piard; Isabelle Lebhar; Ai-Ling Tian; Cassandra Thelemaque; Carolina Alves Costa Silva; Eric Deutsch; Yohann Loriot; Nicola Segata; Gianmarco Piccinno; Geke A. P. Hospers; Saman Maleki Vareki; Michael S. Silverman; John G. Lenehan; Véronique Bataille; David Boulate; Tatiana Kuznetsova; Rinse K. Weersma; Meriem Messaoudene; Sylvère Durand; Carlijn M. van der Aalst; Harry J. de Koning; Beatrice Schuler-Thurner; I. Jolanda M. de Vries; Edmond Rafie; Renée Maria Saliby; Marc Machaalani; Sebastian Haferkamp; Bastian Schilling; Serena Porcari; Chiara Ciccarese; Roberto Iacovelli; Chiara Cremolini; Toni K. Choueiri; Arielle Elkrief; Guido Kroemer; Lucie Heinzerling; Kenji Chamoto; Gianluca Ianiro; Bertrand Routy; Lisa Derosa; Nikos Paragios; Laurence Zitvogel
errShare
errSave
errShare
errSave
HPK1 inhibitor NDI-101150 as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: Phase 1/2 trial results
err2026-05-06
err0
errOAAI
errDavid A. Braun; Marcus S. Noel; Ryan H. Moy; Kurt Demel; Martin Gutierrez; Sunil Sharma; Arif Hussain; Shirish Gadgeel; Julio Peguero; Toni K. Choueiri; Hamid Emamekhoo; Brian Van Tine; Rama Balaraman; GiNell Elliott; Sritama Nath; Scott R. Daigle; Pavan Kumar; Anita Scheuber; David Sommerhalder
errShare
errSave
The clinical landscape of HIF2α inhibitors in oncology
err2026-04-28
err0
PREAI
errEddy Saad; Marc Machaalani; David F. McDermott; Toni K. Choueiri
errShare
errSave
A Mitochondrial Plasma Proteomic Signature Identifies Metastatic Chromophobe Renal Cell Carcinoma
errCancers
IF4.4
err2026-04-03
err0
errOAAI
errClara Steiner; Tiegang Han; Steven Safi; Wafaa Bzeih; Hadi Mansour; Eddy Saad; Jessica F. Williams; Michelle S. Hirsch; Vinay K. Giri; Liliana Ascione; Yehonatan Elon; Adam P. Dicker; Yan Tang; Toni K. Choueiri; Elizabeth P. Henske; Wenxin Xu
errShare
errSave
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial☆
err2026-03-03
err0
errOAAI
errT.K. Choueiri; L. Albigès; D.F. McDermott; H.J. Hammers; B. Escudier; M. Burotto; E.R. Plimack; C. Porta; S. George; T. Powles; F. Donskov; M.B. Atkins; H. Gurney; C.K. Kollmannsberger; M.-O. Grimm; C. Barrios; D. Castellano; V. Grünwald; Y. Tomita; B.I. Rini
errShare
errSave
Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and BAP1 loss
err2026-02-20
err0
errOAAI
errSabrina Y. Camp; Meng Xiao He; Michael S. Cuoco; Amanda E. Garza; Sherin Xirenayi; Ziad Bakouny; Eddy Saad; Jad El Masri; Erica Pimenta; Kevin Meli; Chris Labaki; Breanna M. Titchen; Yun Jee Kang; Jack Horst; Rachel Trowbridge; Erin Shannon; Karla Helvie; Aaron R. Thorner; Sébastien Vigneau; Angie Mayorga; Jahnavi Kodali; Hannah Lachmayr; Meredith Bemus; Pengsheng Chen; Haiteng Deng; Jihye Park; Toni K. Choueiri; Kevin Bi; Eliezer M. Van Allen
errShare
errSave
Publisher Correction: argeting of HIF2-driven cachexia in kidney cancer
err2026-01-28
err0
errOAAI
errMuhannad Abu-Remaileh; Laura A. Stransky; Nikita Bhalerao; Nitin H. Shirole; Qinqin Jiang; Eddy Saad; Marc Machaalani; Sean M. Vigeant; Hilina Woldemichael; Charles Xu; Jing Lu; Hairong Wei; Zhihong Liu; William Sun; Kei Enomoto; Toni K. Choueiri; Jason R. Pitarresi; Steven A. Carr; Namrata D. Udeshi; William G. Kaelin
errShare
errSave
Attrition Rates in Metastatic Renal Cell Carcinoma (mRCC) Following First Line Immunotherapy-Based Treatment: Results From the International mRCC Database Consortium (IMDC)
err2026-01-01
err0
PREAI
errLemelin, Audreylie; Zarba, Martin; Takemura, Kosuke; Wells, J. Connor; Chehade, Razane El Hajj; Donskov, Frede; Porta, Camillo; De Velasco, Guillermo; Davis, Ian D.; Wood, Lori A.; Pal, Sumanta K.; Hansen, Aaron R.; Tran, Ben; Bjarnason, Georg A.; Li, Haoran; Kanesvaran, Ravindran; Powles, Thomas; Mckay, Rana R.; Choueiri, Toni K.; Heng, Daniel Y. C.
errShare
errSave
Indeterminate Surgical Margins (Rx) in Renal Cell Carcinoma Surgery: Rates, Predictive Factors, and Impact on Overall Survival
err2026-01-01
err1
PREAI
errFilipas, Dejan K.; Nolazco, Jose, I; Stone, Benjamin, V; Rink, Michael; Beatrici, Edoardo; Labban, Muhieddine; Lipsitz, Stuart R.; Fisch, Margit; Choueiri, Toni K.; Cole, Alexander P.; Trinh, Quoc-Dien; Chang, Steve L.
errShare
errSave
Neutralizing antibody responses to the primary series of a COVID-19 mRNA vaccine in the cancer cohort under active treatment
err2025-12-31
err0
PREAI
errXue, Huijing; Kemp, Troy J.; Li, Chenglei; Roche, Nancy V.; Bakouny, Ziad; Labaki, Chris; Lee, Guo-Shou Mary; Trowbridge, Rachel; Strauss, Sarah; Hughes, Melissa E.; Lin, Nancy U.; Choueiri, Toni K.; Pinto, Ligia A.
errShare
errSave
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers
err2025-12-13
err0
errOAAI
errRana R. McKay MD; Sumanta Pal MD; Wanling Xie MS; David Aggen MD, PhD; Laurence Albiges MD, PhD; Andrea Apolo MD; Michael B. Atkins MD; Rick Bangs MBA, PMP; Kathryn E. Beckermann MD, PhD; Joaquim Bellmunt MD, PhD; Stephanie A. Berg DO; Mehmet A. Bilen MD; David Braun MD, PhD; Maria I. Carlo MD; Jason Efstathiou MD, DPhil; Matthew Galsky MD; Petros Grivas MD, PhD; Shilpa Gupta MD; Naomi Haas MD; A. Ari Hakimi MD; Hans Hammers MD, PhD; Daniel Y. C. Heng MSC; Michelle Hirsch MD, PhD; Gopakumar Iyer MD; Eric Jonasch MD; Vadim S. Koshkin MD; Oleksandr Kryvenko MD; Bryan Lewis JD; Roger Li MD; Surena Matin MD; Benjamin Maughan MD, PharmD; David F. McDermott MD; Bradley McGregor MD; Joshua Meeks MD, PhD; Matthew Milowsky MD; Robert Motzer MD; Andrea Necchi MD; Dan Petrylak MD; Sima Porten MD, MPH; Thomas Powles MBBS, MRCP, MD; Brian Rini MD; Brian Shuch MD; Arlene Siefker-Radtke MD; Guru Sonpavde MD; S. Srikala Sridhar MD; Cristina Suarez MD, PhD; Chad Tang MD; Abhishek Tripathi MD; Michiel S. Van Der Heijden MD, PhD; Martin Voss MD; Wenxin Xu MD; Tian Zhang MD; Jonathan Rosenberg MD; Toni K. Choueiri MD
errShare
errSave
Molecular and clinical insights of trastuzumab deruxtecan efficacy in advanced breast cancer
err2025-12-04
err0
PREAI
errAmin H Nassar; Elias Bou Farhat; Hassan Abushukair; Michel Alchoueriy; Samer Salem; Marc Machaalani; Elio Adib; Elizabeth P Henske; Priyanka Babu; Toni K Choueiri; Mehrdad Rakaee; Lill-Tove Rasmussen Busund; Yamato Takabe; Shun-Fat Lau; Kerri Rall; Abdul Rafeh Naqash; Caroline Jansen; Xiao Wang; Pavan Challa; Paolo Tarantino; Ann H Partridge; Sara M Tolaney; David J Kwiatkowski; Eric P Winer
errShare
errSave
Targeting of HIF2-driven cachexia in kidney cancer
err2025-11-28
err0
errOAAI
errMuhannad Abu-Remaileh; Laura A. Stransky; Nikita Bhalerao; Nitin H. Shirole; Qinqin Jiang; Eddy Saad; Marc Machaalani; Sean M. Vigeant; Hilina Woldemichael; Charles Xu; Jing Lu; Hairong Wei; Zhihong Liu; William Sun; Kei Enomoto; Toni K. Choueiri; Jason R. Pitarresi; Steven A. Carr; Namrata D. Udeshi; William G. Kaelin
errShare
errSave
The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs
err2025-11-14
err0
errOAAI
errTreg Grubb; Pooneh Koochaki; Sayed Matar; Fatme Ghandour; Marc Machaalani; Eddy Saad; Cerise Tang; Eduard Reznik; Jesminara Khatun; Carleigh Salem; Noah Dubasik; David A. Orlando; Matthew G. Guenther; Gyanu Parajuli; Raghvendra M. Srivastava; Steven R. Martinez; Jesse A. Coker; Ritesh R. Kotecha; A. Ari Hakimi; John M. Asara; Timothy A. Chan; Sakari Vanharanta; Shaun R. Stauffer; William G. Kaelin; Sabina Signoretti; Toni K. Choueiri; Abhishek A. Chakraborty
errShare
errSave